Moreover, the incidence of fatigue symptoms in the severe group (50%) was significantly higher than that in the general group (0%) (p=0.182), although it did not reach statistical significance, it presented a clear trend of clinical differences (see Table 4 ).
← all excerpts
Analysis of the twelve cases of immune-related myocarditis caused by cadonilimab.
1
—
—